Central Pacific Bank Trust Division Alnylam Pharmaceuticals, Inc. Transaction History
Central Pacific Bank Trust Division
- $723 Billion
- Q1 2025
A detailed history of Central Pacific Bank Trust Division transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Central Pacific Bank Trust Division holds 2,653 shares of ALNY stock, worth $856,467. This represents 0.1% of its overall portfolio holdings.
Number of Shares
2,653
Previous 1,005
163.98%
Holding current value
$856,467
Previous $236 Million
202.92%
% of portfolio
0.1%
Previous 0.03%
Shares
4 transactions
Others Institutions Holding ALNY
# of Institutions
721Shares Held
111MCall Options Held
978KPut Options Held
881K-
Capital World Investors Los Angeles, CA16.7MShares$5.41 Billion0.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$4.22 Billion0.07% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$3.08 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.15MShares$2.31 Billion0.44% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.42MShares$1.43 Billion0.79% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $39.7B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...